Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$26.32 - $34.31 $26 - $34
1 New
1 $0
Q1 2023

May 15, 2023

BUY
$35.53 - $43.38 $177 - $216
5 New
5 $0
Q2 2022

Aug 04, 2022

BUY
$51.49 - $81.64 $823 - $1,306
16 New
16 $1,000
Q3 2021

Nov 15, 2021

SELL
$54.64 - $61.3 $1,967 - $2,206
-36 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$59.18 - $69.99 $2,130 - $2,519
36 New
36 $2,000
Q4 2019

Feb 13, 2020

SELL
$36.31 - $46.83 $1,052 - $1,358
-29 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$35.66 - $44.99 $1,034 - $1,304
29 New
29 $1,000
Q3 2018

Nov 01, 2018

SELL
$32.85 - $52.0 $361 - $572
-11 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$27.5 - $39.8 $302 - $437
11 New
11 $0

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.